Kadyrkhodjayeva Nigora Saidg‘aniyevna

Nigora Kadykhodjaeva — MD, PhD

Neurologist, Psychiatrist, and Neuropsychologist. Specialist in headache management, chronic pain syndromes, cognitive disorders, and botulinum toxin therapy.

Clinical experience — over 20 years.

Main Areas of Specialization

Headache Disorders: Diagnosis and treatment of chronic migraine, tension-type headache, cluster headache, cervicogenic headache, and occipital neuralgia.

Chronic Pain Syndromes (Pain Management): Comprehensive management of chronic pain, myofascial pain syndrome, and neuropathic pain.

Cognitive Impairment and Dementia: Early detection of memory decline, attention deficits, and other cognitive impairments in adults. Diagnosis and management of patients with Alzheimer’s disease, vascular dementia, and other forms of dementia.

Movement Disorders: Diagnosis and treatment of dystonia, muscle spasms, and other neurological movement disorders.

Neuropsychology: Neuropsychological assessment, evaluation of cognitive functions, and assessment of emotional disturbances associated with neurological conditions.

Clinical Skills and Treatment Methods

Botulinum Toxin Therapy (Botulinum Toxin Type A) — Treatment of chronic migraine, dystonia, and other neurological disorders using botulinum toxin type A.

Trigger Point Injections — Injection-based treatment targeting myofascial trigger points.

Occipital Nerve Block — Blockade of the greater and lesser occipital nerves for occipital neuralgia and selected headache disorders.

Sphenopalatine Ganglion Block (SPG Block) — A nerve block technique used for selected types of headache and facial pain.

Transcranial Magnetic Stimulation (TMS) — A non-invasive neuromodulation technique.

Neuropsychological Testing — Comprehensive assessment of memory, attention, executive functions, and other cognitive abilities.

International Education and Professional Training

United States — Cleveland Clinic

International clinical training program in Pain Management.

Advanced training in contemporary approaches to the diagnosis and treatment of chronic pain syndromes, interventional pain management techniques, and comprehensive care for patients with chronic pain.

United Kingdom — Neuropsychology

Professional training in clinical neuropsychology, neuropsychological assessment, and the evaluation of cognitive functions.

Russia, Moscow — Botulinum Toxin Therapy in Neurology

Certified professional training in the therapeutic use of botulinum toxin type A for neurological disorders.

United Arab Emirates, Dubai — International Advanced Clinical Training Program in Neurology

Advanced clinical training focused on the diagnosis and treatment of neuroimmunological, inflammatory, demyelinating, and neuromuscular disorders, including:

• Multiple sclerosis (MS);

• Neuromyelitis optica spectrum disorders (NMOSD);

• Autoimmune encephalitis and encephalomyelitis;

• Transverse myelitis;

• Guillain–Barré syndrome;

• Myasthenia gravis (various clinical forms);

• Chronic inflammatory demyelinating polyneuropathy (CIDP);

• Other disorders of the central and peripheral nervous systems.

Additional professional training in botulinum toxin therapy.

Scientific and Academic Activities

MD, PhD. Actively engaged in clinical practice, scientific research, and academic teaching in the fields of neurology and neuropsychology.

Main Research Interests:

• Chronic primary headache disorders and their association with cognitive impairment.

• Early detection of cognitive decline and identification of dementia risk factors.

• Alzheimer’s disease and neurodegenerative disorders.

• Modern approaches to the prevention and treatment of chronic headache disorders.

Innovation Proposal (2017):

“Modified Treatment Methods for Primary Chronic Headache Disorders Using Botulinum Toxin Type A.”

International Professional Memberships

• European Academy of Neurology (EAN)

• International Parkinson and Movement Disorder Society (MDS)

Additional Certifications

Certified in internationally recognized programs, including BLS, ACLS (American Heart Association), and ITLS.